Show simple item record

dc.contributor.authorMolloy, M.
dc.contributor.authorComer, R.
dc.contributor.authorRogers, P.
dc.contributor.authorDowling, Maura
dc.contributor.authorMeskell, P.
dc.contributor.authorAsbury, K.
dc.contributor.authorO'Leary, M.
dc.date.accessioned2018-12-13T12:27:53Z
dc.date.available2018-12-13T12:27:53Z
dc.date.issued2015-12-21
dc.identifier.citationMolloy, M., Comer, R., Rogers, P., Dowling, M., Meskell, P., Asbury, K., & O’Leary, M. (2016). High risk HPV testing following treatment for cervical intraepithelial neoplasia. Irish Journal of Medical Science (1971 -), 185(4), 895-900. doi: 10.1007/s11845-015-1392-4en_IE
dc.identifier.issn1863-4362
dc.identifier.urihttp://hdl.handle.net/10379/14697
dc.description.abstractTo determine the results of combined cytology and high-risk human papilloma virus (HR HPV) tests at 6 and 18 months postcolposcopy treatment at one Irish colposcopy centre.All women who attended the centre's colposcopy smear clinic for a co-test 6 months (initial test) posttreatment were included in the audit (n = 251).The results revealed negative HR HPV for 79 % (n = 198) of women tested 6 months after treatment and positive results for 21 % (n = 53). HR HPV testing was more sensitive than cytology and led to early detection of residual disease. No women with negative HR HPV had high-grade cytology.HR HPV is more sensitive than cytology for detection of persistent CIN. However, 19 women with positive HR HPV had normal colposcopy with no persistent CIN detected. A national cost-benefit analysis is recommended to determine the value of the second co-test.en_IE
dc.language.isoenen_IE
dc.publisherSpringer Verlagen_IE
dc.relation.ispartofIrish Journal Of Medical Scienceen
dc.subjectAuditen_IE
dc.subjectCervical intraepithelial neoplasiaen_IE
dc.subjectColposcopyen_IE
dc.subjectHPV DNA testsen_IE
dc.subjectPapanicolaou testen_IE
dc.subjectLOOP EXCISIONen_IE
dc.subjectPREVENTIONen_IE
dc.subjectPREDICTIONen_IE
dc.subjectDISEASEen_IE
dc.titleHigh risk HPV testing following treatment for cervical intraepithelial neoplasiaen_IE
dc.typeArticleen_IE
dc.date.updated2018-12-03T21:18:08Z
dc.identifier.doi10.1007/s11845-015-1392-4
dc.local.publishedsourcehttps://dx.doi.org/10.1007/s11845-015-1392-4en_IE
dc.description.peer-reviewedpeer-reviewed
dc.internal.rssid11779274
dc.local.contactMaura Dowling, School Of Nursing And Midwifery, Room 415 Aras Moyola, Newcastle Road, Galway. 3833 Email: maura.dowling@nuigalway.ie
dc.local.copyrightcheckedYes
dc.local.versionPUBLISHED
nui.item.downloads202


Files in this item

Attribution-NonCommercial-NoDerivs 3.0 Ireland
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. Please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.

The following license files are associated with this item:

Thumbnail

This item appears in the following Collection(s)

Show simple item record